Cargando…

The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription

BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical in...

Descripción completa

Detalles Bibliográficos
Autores principales: Beers, Erna, Egberts, Toine C. G., Leufkens, Hubert G. M., Jansen, Paul A. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745417/
https://www.ncbi.nlm.nih.gov/pubmed/23977208
http://dx.doi.org/10.1371/journal.pone.0072060
_version_ 1782280691513294848
author Beers, Erna
Egberts, Toine C. G.
Leufkens, Hubert G. M.
Jansen, Paul A. F.
author_facet Beers, Erna
Egberts, Toine C. G.
Leufkens, Hubert G. M.
Jansen, Paul A. F.
author_sort Beers, Erna
collection PubMed
description BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical industries consider necessary for rational drug prescribing to older individuals. METHODS AND FINDINGS: A 29-item-questionnaire was composed, considering the representation in trials, pharmacokinetics, efficacy, safety, and convenience of use in older individuals, with space for additions. Forty-three European professionals with an interest in medication for older individuals were included. In order to investigate their relevance, five items were included in a second questionnaire, with 11 control items. Median scores, differences between clinical and non-clinical respondents and response consistency were analysed. Consistency was present in 10 control items. Therefore, all items of the first questionnaire and the five additional items were analysed. Thirty-seven (86%) respondents returned the first questionnaire; 31/37 (84%) the second. Information about age-related differences in adverse events, locomotor effects, drug-disease interactions, dosing instructions, and information about the proportion of included 65+ patients was considered necessary by most respondents. Clinicians considered information significantly more important than the non-clinical respondents about the inclusion of 75+, time-until-benefit in older people, anticholinergic effects, drug-disease interactions, and convenience of use. Main study limitations are the focus on information for daily practice, while the ICH E7 guideline is a legislative document focused on market approval of a new medicine. Also, a questionnaire with a Likert scale has its limitations; this was addressed by providing space for comments. CONCLUSIONS: This study reveals that items considered necessary are currently not included in the ICH E7 guideline. Also, clinicians’ and non-clinicians’ opinions differed significantly in 15% of the items. Therefore, all stakeholders should collaborate to improve the availability of information for the rational prescribing to older individuals.
format Online
Article
Text
id pubmed-3745417
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37454172013-08-23 The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription Beers, Erna Egberts, Toine C. G. Leufkens, Hubert G. M. Jansen, Paul A. F. PLoS One Research Article BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical industries consider necessary for rational drug prescribing to older individuals. METHODS AND FINDINGS: A 29-item-questionnaire was composed, considering the representation in trials, pharmacokinetics, efficacy, safety, and convenience of use in older individuals, with space for additions. Forty-three European professionals with an interest in medication for older individuals were included. In order to investigate their relevance, five items were included in a second questionnaire, with 11 control items. Median scores, differences between clinical and non-clinical respondents and response consistency were analysed. Consistency was present in 10 control items. Therefore, all items of the first questionnaire and the five additional items were analysed. Thirty-seven (86%) respondents returned the first questionnaire; 31/37 (84%) the second. Information about age-related differences in adverse events, locomotor effects, drug-disease interactions, dosing instructions, and information about the proportion of included 65+ patients was considered necessary by most respondents. Clinicians considered information significantly more important than the non-clinical respondents about the inclusion of 75+, time-until-benefit in older people, anticholinergic effects, drug-disease interactions, and convenience of use. Main study limitations are the focus on information for daily practice, while the ICH E7 guideline is a legislative document focused on market approval of a new medicine. Also, a questionnaire with a Likert scale has its limitations; this was addressed by providing space for comments. CONCLUSIONS: This study reveals that items considered necessary are currently not included in the ICH E7 guideline. Also, clinicians’ and non-clinicians’ opinions differed significantly in 15% of the items. Therefore, all stakeholders should collaborate to improve the availability of information for the rational prescribing to older individuals. Public Library of Science 2013-08-16 /pmc/articles/PMC3745417/ /pubmed/23977208 http://dx.doi.org/10.1371/journal.pone.0072060 Text en © 2013 Beers et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Beers, Erna
Egberts, Toine C. G.
Leufkens, Hubert G. M.
Jansen, Paul A. F.
The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
title The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
title_full The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
title_fullStr The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
title_full_unstemmed The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
title_short The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
title_sort views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescription
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745417/
https://www.ncbi.nlm.nih.gov/pubmed/23977208
http://dx.doi.org/10.1371/journal.pone.0072060
work_keys_str_mv AT beerserna theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT egbertstoinecg theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT leufkenshubertgm theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT jansenpaulaf theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT beerserna viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT egbertstoinecg viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT leufkenshubertgm viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription
AT jansenpaulaf viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription